<DOC>
	<DOCNO>NCT01100216</DOCNO>
	<brief_summary>With advent restriction public smoking , tobacco industry introduce variety novel smokeless tobacco product ( NSTP ) allow continue tobacco use . These product typically low tobacco-specific nitrosamines , carcinogen nicotine conventional smokeless product market . No study compare effect NSTP medicinal nicotine product ( MNP ) smokeless tobacco user whether NSTP product may serve cessation tool smokeless tobacco user . Our hypothesis effect product directly relate nicotine content sensory effect . Products produce great effect outcome measure may serve potential cessation tool .</brief_summary>
	<brief_title>Human Laboratory Study Smokeless Tobacco Products</brief_title>
	<detailed_description>Treatment 3-period crossover study use Commit Nicotine Lozenge , Stonewall Disposable Tobacco Pieces Camel Snus Frost Pouches . Each period last 14 day 11 day product use 1.5 day abstinence nicotine-containing product total 10 week . Participants begin study complete baseline assessment product , Skoal Wintergreen .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>Subjects 20 male smokeless tobacco ( SLT ) user seek quit ( le 5 % female use SLT . Subjects Skoal Wintergreen SLT user , since commonly use SLT use minttype flavorant . Subjects use SLT least 1 year.. Subjects English speak reading . Provide write informed consent . Subjects use tobacco product ( i.e. , cigarette , cigar ) nicotine product past 6 month . Subjects take medication might affect outcome laboratory measure . Subjects history major mood , think , anxiety attentional disorder .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>smokeless tobacco</keyword>
	<keyword>nicotine</keyword>
	<keyword>snus</keyword>
	<keyword>snuff</keyword>
	<keyword>chew tobacco</keyword>
	<keyword>oral tobacco</keyword>
</DOC>